Morepen Labs incorporates wholly owned subsidiary in Dubai
Gurugram: Morepen Labs has incorporated a wholly owned subsidiary, MOREPEN LABS - FZCO, in Dubai, United Arab Emirates.
The new entity was incorporated on June 18, 2025, in the Free Zone of Dubai, and will focus on trading in pharmaceuticals and medicines outside the UAE, the company said in a BSE filing.
"We are pleased to inform that “MOREPEN LABS - FZCO”, a wholly owned subsidiary of the company, has been incorporated today i.e., 18th June, 2025, in Free Zone, Dubai, United Arab Emirates," Morepen stated in a BSE filing.
According to the company, the authorized capital of Morepen Labs – FZCO is AED 50,000, divided into 5,000 ordinary shares of AED 10 each. The investment was made in cash.
The incorporated entity being a wholly owned subsidiary, is a related party of the company. The promoter/ promoter group do not have any interest in the newly formed entity.
As the entity is newly formed, no financial history or past turnover is applicable. No government or regulatory approvals were required for the incorporation.
In April, the Medical Dialogues team reported that the change in the name of subsidiary of Morepen Labs from Morepen Medtech Limited to Morepen Medipath Limited.
That same month, the company also announced an expansion of its salesforce, with plans to onboard over 1,000 professionals over the next three years. Of these, 200 new team members are expected to join in FY26. The recruitment drive is part of Morepen’s strategy to strengthen engagement with doctors, pharmacies, patients, and healthcare professionals across India.
Read also: Morepen Labs names Kushal Suri as President - International Growth
Morepen Laboratories Ltd. is an Indian pharmaceutical company with a global footprint across 82 countries. All APIs are manufactured in-house at USFDA-approved facilities.
Read also: Morepen Labs names Vivan Prashar as functional head, (Operations-API)
